Share Price and Basic Stock Data
Last Updated: November 6, 2025, 10:34 pm
| PEG Ratio | 7.38 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Timken India Ltd operates in the bearings industry, reporting a current market capitalization of ₹22,828 Cr. The company’s revenue from operations has shown a consistent upward trajectory, with sales increasing from ₹2,203 Cr in FY 2022 to ₹2,910 Cr in FY 2024, and further rising to ₹3,173 Cr in TTM. Quarterly sales also reflect this growth, with Q1 FY 2025 sales reaching ₹940 Cr, up from ₹803 Cr in Q4 FY 2023. This revenue growth can be attributed to the company’s strategic position in the bearings sector, which is essential for various industrial applications, including automotive and manufacturing. Timken India’s operating profit margin (OPM) stood at 19% in FY 2024, slightly declining from 20% in FY 2023, indicating effective cost management amidst rising operational challenges. The company’s adaptability to market dynamics and its focus on innovation have positioned it well to capture growth opportunities in both domestic and international markets.
Profitability and Efficiency Metrics
Timken India reported a net profit of ₹455 Cr for the trailing twelve months, with a net profit margin of 14.21% in FY 2025. The company’s return on equity (ROE) stood at a commendable 17.0%, while return on capital employed (ROCE) was even higher at 20.9%. These figures reflect strong profitability and efficient utilization of capital. The interest coverage ratio (ICR) was exceptionally high at 149.64x, indicating the company’s ability to comfortably meet its interest obligations, a sign of financial health and stability. However, the operating profit margin (OPM) has shown fluctuations, with a high of 23% in FY 2022 and a decrease to 19% in FY 2025, suggesting potential pressures on cost management. The cash conversion cycle (CCC) of 129 days demonstrates effective management of working capital, although it is essential to monitor any shifts that could adversely impact liquidity.
Balance Sheet Strength and Financial Ratios
Timken India’s balance sheet reflects significant strength, with total assets standing at ₹3,425 Cr and total liabilities at ₹3,425 Cr as of FY 2025. Notably, the company’s borrowings are minimal, recorded at just ₹17 Cr, which positions it well against competitors that may carry higher debt levels. The reserves also increased to ₹2,770 Cr, showcasing a strong retained earnings position that supports future growth initiatives. The price-to-book value (P/BV) ratio is at 7.27x, indicating a premium valuation compared to typical industry ranges, which suggests robust investor confidence in the company’s growth prospects. Additionally, the current ratio of 3.82x indicates excellent short-term financial health and liquidity, far exceeding the typical sector norm of 1.5x. This strong financial position allows Timken India to pursue strategic investments and manage operational challenges effectively.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Timken India reflects a stable and diversified ownership structure, with promoters holding 51.05% of the equity as of March 2025. Foreign Institutional Investors (FIIs) and Domestic Institutional Investors (DIIs) have increased their stakes to 7.39% and 29.72%, respectively, indicating growing institutional interest in the company. This shift in shareholding dynamics is encouraging, as it often signifies confidence in the company’s long-term growth potential. The number of shareholders has also risen to 76,566, suggesting increasing retail investor interest. However, the promoter holding has seen a decline from 67.80% in December 2022, which may raise concerns about potential dilution of control. The dividend payout ratio is relatively low at 4.20%, which may reflect a strategy focused on reinvestment rather than immediate returns, appealing to growth-oriented investors.
Outlook, Risks, and Final Insight
Moving forward, Timken India is well-positioned to capitalize on growth opportunities driven by increasing demand in the bearings sector. The company’s strong financial metrics and minimal debt provide a solid foundation for expansion and innovation. However, potential risks include fluctuations in raw material prices and economic downturns that could affect demand across key sectors. Additionally, the declining promoter stake could impact shareholder confidence if not managed carefully. Overall, Timken India’s strategic focus on operational efficiency and market expansion presents a favorable outlook, though stakeholders must remain vigilant regarding market dynamics and competitive pressures. The company’s ability to maintain profitability and manage costs will be crucial in sustaining its growth trajectory in the coming years.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Timken India Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Galaxy Bearings Ltd | 241 Cr. | 756 | 1,187/601 | 39.4 | 337 | 0.00 % | 16.1 % | 13.7 % | 10.0 |
| Deccan Bearings Ltd | 217 Cr. | 108 | 109/81.2 | 0.32 | 0.00 % | 107 % | 107 % | 10.0 | |
| Benara Bearings & Pistons Ltd | 20.4 Cr. | 11.5 | 24.4/11.3 | 4.73 | 0.00 % | 26.1 % | 512 % | 10.0 | |
| Austin Engineering Company Ltd | 52.7 Cr. | 151 | 225/136 | 12.5 | 189 | 0.00 % | 8.04 % | 6.00 % | 10.0 |
| Timken India Ltd | 22,973 Cr. | 3,054 | 3,576/2,200 | 50.5 | 368 | 1.18 % | 20.9 % | 17.0 % | 10.0 |
| Industry Average | 14,490.57 Cr | 1,187.28 | 32.54 | 210.63 | 0.65% | 29.53% | 80.38% | 7.22 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 699 | 695 | 609 | 803 | 718 | 682 | 612 | 898 | 784 | 753 | 671 | 940 | 809 |
| Expenses | 528 | 563 | 506 | 650 | 582 | 546 | 510 | 699 | 643 | 620 | 565 | 730 | 666 |
| Operating Profit | 172 | 132 | 104 | 153 | 136 | 136 | 102 | 199 | 141 | 133 | 107 | 210 | 142 |
| OPM % | 25% | 19% | 17% | 19% | 19% | 20% | 17% | 22% | 18% | 18% | 16% | 22% | 18% |
| Other Income | 11 | 22 | 14 | 7 | 9 | 10 | 11 | 11 | 12 | 12 | 13 | 14 | 10 |
| Interest | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 22 | 22 | 22 | 21 | 21 | 21 | 21 | 22 | 22 | 21 | 21 | 21 | 21 |
| Profit before tax | 160 | 131 | 95 | 137 | 123 | 124 | 91 | 187 | 130 | 124 | 98 | 202 | 130 |
| Tax % | 26% | 26% | 26% | 24% | 27% | 25% | 26% | 24% | 26% | 27% | 24% | 7% | 20% |
| Net Profit | 118 | 98 | 71 | 105 | 90 | 93 | 68 | 141 | 96 | 90 | 74 | 187 | 104 |
| EPS in Rs | 15.70 | 12.98 | 9.38 | 13.89 | 11.98 | 12.37 | 8.98 | 18.80 | 12.80 | 11.96 | 9.88 | 24.84 | 13.86 |
Last Updated: August 1, 2025, 10:10 am
Below is a detailed analysis of the quarterly data for Timken India Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 809.00 Cr.. The value appears to be declining and may need further review. It has decreased from 940.00 Cr. (Mar 2025) to 809.00 Cr., marking a decrease of 131.00 Cr..
- For Expenses, as of Jun 2025, the value is 666.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 730.00 Cr. (Mar 2025) to 666.00 Cr., marking a decrease of 64.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 142.00 Cr.. The value appears to be declining and may need further review. It has decreased from 210.00 Cr. (Mar 2025) to 142.00 Cr., marking a decrease of 68.00 Cr..
- For OPM %, as of Jun 2025, the value is 18.00%. The value appears to be declining and may need further review. It has decreased from 22.00% (Mar 2025) to 18.00%, marking a decrease of 4.00%.
- For Other Income, as of Jun 2025, the value is 10.00 Cr.. The value appears to be declining and may need further review. It has decreased from 14.00 Cr. (Mar 2025) to 10.00 Cr., marking a decrease of 4.00 Cr..
- For Interest, as of Jun 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 21.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 21.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 130.00 Cr.. The value appears to be declining and may need further review. It has decreased from 202.00 Cr. (Mar 2025) to 130.00 Cr., marking a decrease of 72.00 Cr..
- For Tax %, as of Jun 2025, the value is 20.00%. The value appears to be increasing, which may not be favorable. It has increased from 7.00% (Mar 2025) to 20.00%, marking an increase of 13.00%.
- For Net Profit, as of Jun 2025, the value is 104.00 Cr.. The value appears to be declining and may need further review. It has decreased from 187.00 Cr. (Mar 2025) to 104.00 Cr., marking a decrease of 83.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 13.86. The value appears to be declining and may need further review. It has decreased from 24.84 (Mar 2025) to 13.86, marking a decrease of 10.98.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:15 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 719 | 926 | 1,042 | 1,056 | 1,233 | 1,664 | 1,618 | 1,411 | 2,203 | 2,807 | 2,910 | 3,148 | 3,173 |
| Expenses | 646 | 792 | 880 | 898 | 1,070 | 1,375 | 1,254 | 1,159 | 1,692 | 2,246 | 2,337 | 2,556 | 2,581 |
| Operating Profit | 73 | 134 | 162 | 158 | 163 | 289 | 363 | 252 | 511 | 560 | 572 | 592 | 592 |
| OPM % | 10% | 14% | 16% | 15% | 13% | 17% | 22% | 18% | 23% | 20% | 20% | 19% | 19% |
| Other Income | 10 | 6 | 3 | 10 | 21 | 16 | 23 | 20 | 14 | 53 | 41 | 50 | 49 |
| Interest | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 1 | 2 | 3 | 4 | 4 | 4 |
| Depreciation | 16 | 17 | 22 | 29 | 43 | 79 | 77 | 75 | 84 | 87 | 85 | 85 | 84 |
| Profit before tax | 66 | 122 | 142 | 138 | 140 | 224 | 306 | 195 | 438 | 524 | 524 | 553 | 553 |
| Tax % | 32% | 34% | 35% | 30% | 34% | 34% | 20% | 27% | 25% | 25% | 25% | 19% | |
| Net Profit | 45 | 81 | 92 | 97 | 92 | 149 | 246 | 143 | 327 | 391 | 392 | 447 | 455 |
| EPS in Rs | 6.58 | 11.87 | 13.50 | 14.29 | 13.53 | 19.76 | 32.72 | 19.04 | 43.49 | 51.95 | 52.13 | 59.48 | 60.54 |
| Dividend Payout % | 99% | 25% | 7% | 7% | 7% | 5% | 153% | 8% | 3% | 3% | 5% | 61% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 80.00% | 13.58% | 5.43% | -5.15% | 61.96% | 65.10% | -41.87% | 128.67% | 19.57% | 0.26% | 14.03% |
| Change in YoY Net Profit Growth (%) | 0.00% | -66.42% | -8.15% | -10.59% | 67.11% | 3.14% | -106.97% | 170.54% | -109.10% | -19.32% | 13.77% |
Timken India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 14% |
| 3 Years: | 13% |
| TTM: | 7% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 13% |
| 3 Years: | 11% |
| TTM: | 14% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 20% |
| 3 Years: | -4% |
| 1 Year: | -24% |
| Return on Equity | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 18% |
| 3 Years: | 18% |
| Last Year: | 17% |
Last Updated: September 5, 2025, 1:46 pm
Balance Sheet
Last Updated: June 16, 2025, 11:11 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 68 | 68 | 68 | 68 | 68 | 75 | 75 | 75 | 75 | 75 | 75 | 75 |
| Reserves | 314 | 370 | 462 | 550 | 634 | 1,266 | 1,501 | 1,268 | 1,582 | 1,962 | 2,342 | 2,770 |
| Borrowings | 3 | 3 | 4 | 8 | 16 | 23 | 24 | 35 | 32 | 31 | 25 | 17 |
| Other Liabilities | 114 | 144 | 168 | 251 | 261 | 411 | 380 | 510 | 505 | 489 | 545 | 564 |
| Total Liabilities | 500 | 585 | 702 | 877 | 979 | 1,775 | 1,980 | 1,888 | 2,194 | 2,557 | 2,988 | 3,425 |
| Fixed Assets | 97 | 107 | 137 | 231 | 251 | 795 | 748 | 818 | 860 | 843 | 853 | 809 |
| CWIP | 26 | 27 | 21 | 58 | 54 | 64 | 157 | 97 | 50 | 53 | 104 | 592 |
| Investments | 23 | 17 | 38 | 91 | 55 | 176 | 13 | 0 | 99 | 236 | 161 | 117 |
| Other Assets | 354 | 435 | 506 | 498 | 619 | 741 | 1,063 | 973 | 1,185 | 1,424 | 1,870 | 1,908 |
| Total Assets | 500 | 585 | 702 | 877 | 979 | 1,775 | 1,980 | 1,888 | 2,194 | 2,557 | 2,988 | 3,425 |
Below is a detailed analysis of the balance sheet data for Timken India Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 75.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 75.00 Cr..
- For Reserves, as of Mar 2025, the value is 2,770.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,342.00 Cr. (Mar 2024) to 2,770.00 Cr., marking an increase of 428.00 Cr..
- For Borrowings, as of Mar 2025, the value is 17.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 25.00 Cr. (Mar 2024) to 17.00 Cr., marking a decrease of 8.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 564.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 545.00 Cr. (Mar 2024) to 564.00 Cr., marking an increase of 19.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 3,425.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,988.00 Cr. (Mar 2024) to 3,425.00 Cr., marking an increase of 437.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 809.00 Cr.. The value appears to be declining and may need further review. It has decreased from 853.00 Cr. (Mar 2024) to 809.00 Cr., marking a decrease of 44.00 Cr..
- For CWIP, as of Mar 2025, the value is 592.00 Cr.. The value appears strong and on an upward trend. It has increased from 104.00 Cr. (Mar 2024) to 592.00 Cr., marking an increase of 488.00 Cr..
- For Investments, as of Mar 2025, the value is 117.00 Cr.. The value appears to be declining and may need further review. It has decreased from 161.00 Cr. (Mar 2024) to 117.00 Cr., marking a decrease of 44.00 Cr..
- For Other Assets, as of Mar 2025, the value is 1,908.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,870.00 Cr. (Mar 2024) to 1,908.00 Cr., marking an increase of 38.00 Cr..
- For Total Assets, as of Mar 2025, the value is 3,425.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,988.00 Cr. (Mar 2024) to 3,425.00 Cr., marking an increase of 437.00 Cr..
Notably, the Reserves (2,770.00 Cr.) exceed the Borrowings (17.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 70.00 | 131.00 | 158.00 | 150.00 | 147.00 | 266.00 | 339.00 | 217.00 | 479.00 | 529.00 | 547.00 | 575.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 75 | 69 | 68 | 66 | 66 | 66 | 66 | 96 | 89 | 75 | 82 | 81 |
| Inventory Days | 112 | 110 | 108 | 111 | 121 | 125 | 124 | 171 | 171 | 125 | 142 | 124 |
| Days Payable | 60 | 57 | 65 | 92 | 97 | 92 | 92 | 156 | 100 | 76 | 82 | 76 |
| Cash Conversion Cycle | 128 | 122 | 110 | 85 | 90 | 99 | 98 | 112 | 160 | 124 | 142 | 129 |
| Working Capital Days | 104 | 98 | 91 | 70 | 96 | 80 | 74 | 86 | 117 | 102 | 111 | 107 |
| ROCE % | 19% | 30% | 30% | 24% | 21% | 22% | 21% | 13% | 29% | 28% | 23% | 21% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Nippon India Small Cap Fund | 1,134,218 | 0.84 | 384.24 | 1,134,218 | 2025-04-22 17:25:17 | 0% |
| HDFC Mid-Cap Opportunities Fund - Regular Plan | 791,549 | 0.45 | 268.15 | 791,549 | 2025-04-22 13:31:13 | 0% |
| PGIM India Midcap Opportunities Fund | 701,519 | 2.39 | 237.65 | 701,519 | 2025-04-22 17:25:17 | 0% |
| Mirae Asset Large Cap Fund | 682,131 | 0.61 | 231.09 | 682,131 | 2025-04-22 17:25:17 | 0% |
| Nippon India Growth Fund | 660,386 | 0.92 | 223.72 | 660,386 | 2025-04-22 17:25:17 | 0% |
| SBI Large & Midcap Fund | 595,174 | 1.01 | 201.63 | 595,174 | 2025-04-22 17:25:17 | 0% |
| ICICI Prudential Focused Equity Fund | 405,990 | 2.02 | 137.54 | 405,990 | 2025-04-22 17:25:17 | 0% |
| SBI Contra Fund | 362,333 | 0.52 | 122.75 | 362,333 | 2025-04-22 17:25:17 | 0% |
| Nippon India ELSS Tax Saver Fund | 346,781 | 0.83 | 117.48 | 346,781 | 2025-04-22 17:25:17 | 0% |
| HDFC Large and Mid Cap Fund - Regular Plan | 344,711 | 0.73 | 116.78 | 344,711 | 2025-04-22 17:25:17 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 59.48 | 52.13 | 51.95 | 43.49 | 19.03 |
| Diluted EPS (Rs.) | 59.48 | 52.13 | 51.95 | 43.49 | 19.03 |
| Cash EPS (Rs.) | 70.75 | 63.46 | 63.54 | 54.70 | 28.99 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 378.21 | 321.36 | 270.83 | 220.28 | 178.61 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 378.21 | 321.36 | 270.83 | 220.28 | 178.61 |
| Dividend / Share (Rs.) | 36.00 | 2.50 | 1.50 | 1.50 | 1.50 |
| Revenue From Operations / Share (Rs.) | 418.49 | 386.81 | 373.13 | 292.91 | 187.52 |
| PBDIT / Share (Rs.) | 85.32 | 81.52 | 81.57 | 69.79 | 36.08 |
| PBIT / Share (Rs.) | 74.05 | 70.19 | 69.97 | 58.58 | 26.12 |
| PBT / Share (Rs.) | 73.48 | 69.69 | 69.60 | 58.25 | 25.93 |
| Net Profit / Share (Rs.) | 59.48 | 52.13 | 51.95 | 43.49 | 19.03 |
| PBDIT Margin (%) | 20.38 | 21.07 | 21.86 | 23.82 | 19.23 |
| PBIT Margin (%) | 17.69 | 18.14 | 18.75 | 19.99 | 13.93 |
| PBT Margin (%) | 17.55 | 18.01 | 18.65 | 19.88 | 13.82 |
| Net Profit Margin (%) | 14.21 | 13.47 | 13.92 | 14.84 | 10.15 |
| Return on Networth / Equity (%) | 15.72 | 16.22 | 19.18 | 19.74 | 10.65 |
| Return on Capital Employeed (%) | 19.11 | 20.99 | 24.71 | 25.06 | 13.54 |
| Return On Assets (%) | 13.06 | 13.12 | 15.28 | 14.91 | 7.58 |
| Total Debt / Equity (X) | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 |
| Asset Turnover Ratio (%) | 0.98 | 1.05 | 1.18 | 1.08 | 0.72 |
| Current Ratio (X) | 3.82 | 3.91 | 3.77 | 2.89 | 2.16 |
| Quick Ratio (X) | 2.56 | 2.50 | 2.44 | 1.61 | 1.32 |
| Inventory Turnover Ratio (X) | 4.80 | 4.71 | 1.64 | 1.58 | 1.36 |
| Dividend Payout Ratio (NP) (%) | 4.20 | 2.87 | 2.88 | 3.44 | 262.63 |
| Dividend Payout Ratio (CP) (%) | 3.53 | 2.36 | 2.36 | 2.74 | 172.44 |
| Earning Retention Ratio (%) | 95.80 | 97.13 | 97.12 | 96.56 | -162.63 |
| Cash Earning Retention Ratio (%) | 96.47 | 97.64 | 97.64 | 97.26 | -72.44 |
| Interest Coverage Ratio (X) | 149.64 | 161.83 | 218.11 | 214.54 | 188.33 |
| Interest Coverage Ratio (Post Tax) (X) | 105.31 | 104.49 | 139.91 | 134.68 | 100.36 |
| Enterprise Value (Cr.) | 20293.77 | 21146.70 | 20763.57 | 16203.61 | 9597.83 |
| EV / Net Operating Revenue (X) | 6.45 | 7.27 | 7.40 | 7.35 | 6.80 |
| EV / EBITDA (X) | 31.62 | 34.49 | 33.84 | 30.87 | 35.37 |
| MarketCap / Net Operating Revenue (X) | 6.57 | 7.38 | 7.45 | 7.35 | 6.90 |
| Retention Ratios (%) | 95.79 | 97.12 | 97.11 | 96.55 | -162.63 |
| Price / BV (X) | 7.27 | 8.88 | 10.26 | 9.77 | 7.25 |
| Price / Net Operating Revenue (X) | 6.57 | 7.38 | 7.45 | 7.35 | 6.90 |
| EarningsYield | 0.02 | 0.01 | 0.01 | 0.02 | 0.01 |
After reviewing the key financial ratios for Timken India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 59.48. This value is within the healthy range. It has increased from 52.13 (Mar 24) to 59.48, marking an increase of 7.35.
- For Diluted EPS (Rs.), as of Mar 25, the value is 59.48. This value is within the healthy range. It has increased from 52.13 (Mar 24) to 59.48, marking an increase of 7.35.
- For Cash EPS (Rs.), as of Mar 25, the value is 70.75. This value is within the healthy range. It has increased from 63.46 (Mar 24) to 70.75, marking an increase of 7.29.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 378.21. It has increased from 321.36 (Mar 24) to 378.21, marking an increase of 56.85.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 378.21. It has increased from 321.36 (Mar 24) to 378.21, marking an increase of 56.85.
- For Dividend / Share (Rs.), as of Mar 25, the value is 36.00. This value exceeds the healthy maximum of 3. It has increased from 2.50 (Mar 24) to 36.00, marking an increase of 33.50.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 418.49. It has increased from 386.81 (Mar 24) to 418.49, marking an increase of 31.68.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 85.32. This value is within the healthy range. It has increased from 81.52 (Mar 24) to 85.32, marking an increase of 3.80.
- For PBIT / Share (Rs.), as of Mar 25, the value is 74.05. This value is within the healthy range. It has increased from 70.19 (Mar 24) to 74.05, marking an increase of 3.86.
- For PBT / Share (Rs.), as of Mar 25, the value is 73.48. This value is within the healthy range. It has increased from 69.69 (Mar 24) to 73.48, marking an increase of 3.79.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 59.48. This value is within the healthy range. It has increased from 52.13 (Mar 24) to 59.48, marking an increase of 7.35.
- For PBDIT Margin (%), as of Mar 25, the value is 20.38. This value is within the healthy range. It has decreased from 21.07 (Mar 24) to 20.38, marking a decrease of 0.69.
- For PBIT Margin (%), as of Mar 25, the value is 17.69. This value is within the healthy range. It has decreased from 18.14 (Mar 24) to 17.69, marking a decrease of 0.45.
- For PBT Margin (%), as of Mar 25, the value is 17.55. This value is within the healthy range. It has decreased from 18.01 (Mar 24) to 17.55, marking a decrease of 0.46.
- For Net Profit Margin (%), as of Mar 25, the value is 14.21. This value exceeds the healthy maximum of 10. It has increased from 13.47 (Mar 24) to 14.21, marking an increase of 0.74.
- For Return on Networth / Equity (%), as of Mar 25, the value is 15.72. This value is within the healthy range. It has decreased from 16.22 (Mar 24) to 15.72, marking a decrease of 0.50.
- For Return on Capital Employeed (%), as of Mar 25, the value is 19.11. This value is within the healthy range. It has decreased from 20.99 (Mar 24) to 19.11, marking a decrease of 1.88.
- For Return On Assets (%), as of Mar 25, the value is 13.06. This value is within the healthy range. It has decreased from 13.12 (Mar 24) to 13.06, marking a decrease of 0.06.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.98. It has decreased from 1.05 (Mar 24) to 0.98, marking a decrease of 0.07.
- For Current Ratio (X), as of Mar 25, the value is 3.82. This value exceeds the healthy maximum of 3. It has decreased from 3.91 (Mar 24) to 3.82, marking a decrease of 0.09.
- For Quick Ratio (X), as of Mar 25, the value is 2.56. This value exceeds the healthy maximum of 2. It has increased from 2.50 (Mar 24) to 2.56, marking an increase of 0.06.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.80. This value is within the healthy range. It has increased from 4.71 (Mar 24) to 4.80, marking an increase of 0.09.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 4.20. This value is below the healthy minimum of 20. It has increased from 2.87 (Mar 24) to 4.20, marking an increase of 1.33.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 3.53. This value is below the healthy minimum of 20. It has increased from 2.36 (Mar 24) to 3.53, marking an increase of 1.17.
- For Earning Retention Ratio (%), as of Mar 25, the value is 95.80. This value exceeds the healthy maximum of 70. It has decreased from 97.13 (Mar 24) to 95.80, marking a decrease of 1.33.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 96.47. This value exceeds the healthy maximum of 70. It has decreased from 97.64 (Mar 24) to 96.47, marking a decrease of 1.17.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 149.64. This value is within the healthy range. It has decreased from 161.83 (Mar 24) to 149.64, marking a decrease of 12.19.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 105.31. This value is within the healthy range. It has increased from 104.49 (Mar 24) to 105.31, marking an increase of 0.82.
- For Enterprise Value (Cr.), as of Mar 25, the value is 20,293.77. It has decreased from 21,146.70 (Mar 24) to 20,293.77, marking a decrease of 852.93.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 6.45. This value exceeds the healthy maximum of 3. It has decreased from 7.27 (Mar 24) to 6.45, marking a decrease of 0.82.
- For EV / EBITDA (X), as of Mar 25, the value is 31.62. This value exceeds the healthy maximum of 15. It has decreased from 34.49 (Mar 24) to 31.62, marking a decrease of 2.87.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 6.57. This value exceeds the healthy maximum of 3. It has decreased from 7.38 (Mar 24) to 6.57, marking a decrease of 0.81.
- For Retention Ratios (%), as of Mar 25, the value is 95.79. This value exceeds the healthy maximum of 70. It has decreased from 97.12 (Mar 24) to 95.79, marking a decrease of 1.33.
- For Price / BV (X), as of Mar 25, the value is 7.27. This value exceeds the healthy maximum of 3. It has decreased from 8.88 (Mar 24) to 7.27, marking a decrease of 1.61.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 6.57. This value exceeds the healthy maximum of 3. It has decreased from 7.38 (Mar 24) to 6.57, marking a decrease of 0.81.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.02, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Timken India Ltd:
- Net Profit Margin: 14.21%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 19.11% (Industry Average ROCE: 29.53%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 15.72% (Industry Average ROE: 80.38%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 105.31
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.56
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 50.5 (Industry average Stock P/E: 32.54)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 14.21%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Bearings | No. 39-42, Electronic City, Phase II, Hosur Road, Bengaluru Karnataka 560100 | tilinvestor@timken.com http://www.timken.com/en-in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Sanjay Koul | Chairman & Managing Director |
| Mr. Avishrant Keshava | Whole Time Director |
| Mr. Ajay Sood | Independent Director |
| Mr. George J Ollapally | Independent Director |
| Dr. Lakshmi Lingam | Independent Director |
| Mrs. Soumitra Hazra | Independent Director |
| Mr. Douglas Smith | Director |
| Mr. Hansal Patel | Director |
FAQ
What is the intrinsic value of Timken India Ltd?
Timken India Ltd's intrinsic value (as of 07 November 2025) is 2557.25 which is 16.27% lower the current market price of 3,054.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 22,973 Cr. market cap, FY2025-2026 high/low of 3,576/2,200, reserves of ₹2,770 Cr, and liabilities of 3,425 Cr.
What is the Market Cap of Timken India Ltd?
The Market Cap of Timken India Ltd is 22,973 Cr..
What is the current Stock Price of Timken India Ltd as on 07 November 2025?
The current stock price of Timken India Ltd as on 07 November 2025 is 3,054.
What is the High / Low of Timken India Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Timken India Ltd stocks is 3,576/2,200.
What is the Stock P/E of Timken India Ltd?
The Stock P/E of Timken India Ltd is 50.5.
What is the Book Value of Timken India Ltd?
The Book Value of Timken India Ltd is 368.
What is the Dividend Yield of Timken India Ltd?
The Dividend Yield of Timken India Ltd is 1.18 %.
What is the ROCE of Timken India Ltd?
The ROCE of Timken India Ltd is 20.9 %.
What is the ROE of Timken India Ltd?
The ROE of Timken India Ltd is 17.0 %.
What is the Face Value of Timken India Ltd?
The Face Value of Timken India Ltd is 10.0.
